Adicon Holdings Limited

Equities

9860

KYG0086A1076

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 11/07/2025 pm IST			5-day change	1st Jan Change
7.100 ^HKD	+1.14%		+6.61%	-21.29%

07/05	Adicon Holdings Acquires Two Medical Firms in Strategic Expansion Move	MT
06/05	Adicon Holdings Says Yuande Weikang Acquisition Valued At HKD191 Million	RE

Adicon Holdings Limited agreed to acquire Suzhou Yuande Weikang Biomedical Co., Ltd. from CHEN Jun for approximately CNY 200 million.

Published on 06/05/2025 at 03:30

Adicon Holdings Limited (SEHK:9860) agreed to acquire Suzhou Yuande Weikang Biomedical Co., Ltd. from CHEN Jun for approximately CNY 200 million on May 6, 2025. The consideration consists of 14.51 million common equity of Adicon Holdings Limited to be issued for common equity of Suzhou Yuande Weikang Biomedical Co., Ltd. Adicon Holdings Limited will pay an earnout/contingent payment common equity.

The transaction is subject to approval by regulatory board / committee.

Latest news about Adicon Holdings Limited

Adicon Holdings Acquires Two Medical Firms in Strategic Expansion Move	07/05	MT
Adicon Holdings Says Yuande Weikang Acquisition Valued At HKD191 Million	06/05	RE
Adicon Holdings Limited agreed to acquire Suzhou Yuande Weikang Biomedical Co., Ltd. from CHEN Jun for approximately CNY 200 million.	06/05	CI
Adicon Holdings Logs FY Profit Attributable RMB47.0 Mln	31/03	RE
Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	31/03	CI
ADICON Launches Share Buyback Program	19/12	MT
Adicon Holdings Limited(SEHK:9860) added to S&P Global BMI Index	23/24/23	CI
Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.	30/24/30	CI
Adicon Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	30/24/30	CI
281,541,805 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-JUN-2024.	29/24/29	CI
Adicon Holdings Limited commences an Equity Buyback for 72,735,479 shares, representing 10% of its issued share capital, under the authorization approved on May 30, 2024.	10/24/10	CI
ADICON Holdings to Repurchase 5% of Shares	05/24/05	MT
Adicon Holdings Limited Approves Appointment of Mr. Zhou Mintao as A Non-Executive Director	30/24/30	CI
ADICON Holdings' 2023 Profit, Revenue Decline	29/24/29	MT
Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/24/28	CI
169,974,982 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-DEC-2023.	29/23/29	CI
ADICON Holdings' Q3 Revenue Falls; Shares Rise 3%	30/23/30	MT
Adicon Holdings Limited Provides Unaudited Consolidated Revenue Guidance for the Three Months Ended September 30, 2023	29/23/29	CI
ADICON's H1 Profit Down as Revenue Slumps 33%	23/23/23	MT
Hong Kong Stocks End Up Flat Over Weak China Factory Data; ADICON Closes 12% Higher at Debut	30/23/30	MT
ADICON Holdings Opens Flat in Hong Kong Trading Debut	30/23/30	MT
ADICON Holdings Raises HK$83.9 Million in Hong Kong IPO	29/23/29	MT
Adicon Holdings Limited has completed an IPO in the amount of HKD 408.9316 million.	28/23/28	CI

Chart Adicon Holdings Limited

Duration

Period

9860: Dynamic Chart

Company Profile

Adicon Holdings Ltd is an investment holding company principally engaged in the provision of independent clinical laboratory (ICL) services. The Company primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The Company's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The Company is also engaged in the sales of medical testing equipment. The Company principally conducts its businesses in the domestic market.

Employees

5,445

Sector

Healthcare Facilities & Services

Calendar

20/08 - Q2 2025 Earnings Release (Projected)

More about the company